Observational studyThe European respiratory journal2017
A longitudinal modelling study estimates acute symptoms of community acquired pneumonia recover to baseline by 10 days.
Observational study in The European respiratory journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis.European journal of internal medicine · 2021Pooled it
- Lefamulin efficacy and safety in a pooled phase 3 clinical trial population with community-acquired bacterial pneumonia and common clinical comorbidities.BMC pulmonary medicine · 2021Trial
- Reducing the complications from community acquired pneumonia: a review.Journal of thoracic disease · 2026Review
- Article
- Article
- Acceptance of pharmacist-led stewardship recommendations for patients with community-acquired pneumonia.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2024Article
- Fixed versus individualized treatment for five common bacterial infectious syndromes: a survey of the perspectives and practices of clinicians.JAC-antimicrobial resistance · 2023Article
- Joint modeling of longitudinal measures of pneumonia and time to convalescence among pneumonia patients: a comparison of separate and joint models.Pneumonia (Nathan Qld.) · 2022Article
- Time to Recovery from Covid-19 and Its Predictors Among Patients Admitted to Treatment Centers of Southern Nations Nationalities and Peoples Region (SNNPR), ETHIOPIA: Multi-Center Retrospective Cohort Study.Infection and drug resistance · 2022Article
- Prevalence and Predictors of Persistent Symptoms After Clearance of SARS-CoV-2 Infection: A Multicenter Study from Egypt.Infection and drug resistance · 2022Article
- Correlation between Platelet miRNA Expression and Coagulation Function in Children with Severe Pneumonia.Evidence-based complementary and alternative medicine : eCAM · 2022Article
- Article
- Pneumonia.Nature reviews. Disease primers · 2021Review
- Symptomatic, biochemical and radiographic recovery in patients with COVID-19.BMJ open respiratory research · 2021Article
- Time to Recovery from Severe Pneumonia and Its Predictors Among Children 2-59 Months of Age Admitted to Pediatric Ward of Nigist Eleni Mohammed Memorial Comprehensive Specialized Hospital, Hossana, Ethiopia: Retrospective Cohort Study.Pediatric health, medicine and therapeutics · 2021Article
- Patient-reported outcome measurement in community-acquired pneumonia: feasibility of routine application in an elderly hospitalized population.Pilot and feasibility studies · 2019Article
- Determinants of Respiratory Rate Trajectory and Recovery Time in Under-Five Children With Severe Pneumonia: A Joint Modeling Approach.Sage open pediatricsArticle
Corrections and comments
- Commented on by
Authors and funding
12 authors.
Funding
Abstract
Our aims were to address three fundamental questions relating to the symptoms of community-acquired pneumonia (CAP): Do patients completely recover from pneumonia symptoms? How long does this recovery take? Which factors influence symptomatic recovery?We prospectively recruited patients at two hospitals in Liverpool, UK, into a longitudinal, observational cohort study and modelled symptom recovery from CAP. We excluded patients with cancer, immunosuppression or advanced dementia, and those who were intubated or palliated from admission. We derived a statistical model to describe symptom patterns.We recruited 169 (52% male) adults. Multivariable analysis demonstrated that the time taken to recover to baseline was determined by the initial severity of symptoms. Severity of symptoms was associated with comorbidity and was inversely related to age. The pattern of symptom recovery was exponential and most patients' symptoms returned to baseline by 10 days.These results will inform the advice given to patients regarding the resolution of their symptoms. The recovery model described here will facilitate the use of symptom recovery as an outcome measure in future clinical trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.